Literature DB >> 11579439

Pharmacokinetics and its role in small molecule drug discovery research.

G R Jang1, R Z Harris, D T Lau.   

Abstract

Pharmacokinetics (PK), which describes the disposition of a drug in the body, should be a primary consideration in the selection of a drug candidate, ultimately contributing to its eventual clinical success or failure. Accordingly, a sound understanding of PK concepts and an appreciation of the judicious use of PK and related (e.g., metabolism, transporter) data in drug discovery can be beneficial to those involved in the process. This review defines important PK parameters (e.g., clearance, volume of distribution, half-life), describes methods of PK data analysis (noncompartmental vs. compartmental) and provides an overview of additional concepts such as allometric scaling, PK/pharmacodynamic modeling, and nonlinear PK. Furthermore, the role and strategic use of PK screens in drug discovery are discussed. Copyright 2001 John Wiley & Sons, Inc. Med Res Rev, 21, No. 5, 382-396, 2001

Mesh:

Year:  2001        PMID: 11579439     DOI: 10.1002/med.1015

Source DB:  PubMed          Journal:  Med Res Rev        ISSN: 0198-6325            Impact factor:   12.944


  12 in total

1.  Nanoparticle pharmacokinetic profiling in vivo using magnetic resonance imaging.

Authors:  Anne M Neubauer; Hoon Sim; Patrick M Winter; Shelton D Caruthers; Todd A Williams; J David Robertson; David Sept; Gregory M Lanza; Samuel A Wickline
Journal:  Magn Reson Med       Date:  2008-12       Impact factor: 4.668

Review 2.  Pharmacokinetic modeling of therapies for systemic lupus erythematosus.

Authors:  Xiaoyan Yang; Catherine M T Sherwin; Tian Yu; Venkata K Yellepeddi; Hermine I Brunner; Alexander A Vinks
Journal:  Expert Rev Clin Pharmacol       Date:  2015-07-09       Impact factor: 5.045

3.  Unraveling the molecular mechanism of l-menthol against cervical cancer based on network pharmacology, molecular docking and in vitro analysis.

Authors:  Harsimran Sidhu; Lalit Kumar Gautam; Neena Capalash
Journal:  Mol Divers       Date:  2022-04-25       Impact factor: 2.943

4.  Prediction of metabolism-induced hepatotoxicity on three-dimensional hepatic cell culture and enzyme microarrays.

Authors:  Kyeong-Nam Yu; Sashi Nadanaciva; Payal Rana; Dong Woo Lee; Bosung Ku; Alexander D Roth; Jonathan S Dordick; Yvonne Will; Moo-Yeal Lee
Journal:  Arch Toxicol       Date:  2017-11-22       Impact factor: 5.153

Review 5.  Multi-scale Modeling in Clinical Oncology: Opportunities and Barriers to Success.

Authors:  Thomas E Yankeelov; Gary An; Oliver Saut; E Georg Luebeck; Aleksander S Popel; Benjamin Ribba; Paolo Vicini; Xiaobo Zhou; Jared A Weis; Kaiming Ye; Guy M Genin
Journal:  Ann Biomed Eng       Date:  2016-07-06       Impact factor: 3.934

Review 6.  The status of pharmacometrics in pregnancy: highlights from the 3(rd) American conference on pharmacometrics.

Authors:  J G Coen van Hasselt; Marilee A Andrew; Mary F Hebert; Joel Tarning; Paolo Vicini; Donald R Mattison
Journal:  Br J Clin Pharmacol       Date:  2012-12       Impact factor: 4.335

7.  Systems biological approach of molecular descriptors connectivity: optimal descriptors for oral bioavailability prediction.

Authors:  Shiek S S J Ahmed; V Ramakrishnan
Journal:  PLoS One       Date:  2012-07-16       Impact factor: 3.240

8.  A novel systems pharmacology model for herbal medicine injection: a case using Reduning injection.

Authors:  Haixing Yang; Wenjuan Zhang; Chao Huang; Wei Zhou; Yao Yao; Zhenzhong Wang; Yan Li; Wei Xiao; Yonghua Wang
Journal:  BMC Complement Altern Med       Date:  2014-11-04       Impact factor: 3.659

9.  Nonstandard Finite Difference Method Applied to a Linear Pharmacokinetics Model.

Authors:  Oluwaseun Egbelowo; Charis Harley; Byron Jacobs
Journal:  Bioengineering (Basel)       Date:  2017-05-04

10.  Preclinical efficacy against acute myeloid leukaemia of SH1573, a novel mutant IDH2 inhibitor approved for clinical trials in China.

Authors:  Zhiqiang Wang; Zhibo Zhang; Yong Li; Li Sun; Dezhen Peng; Danyu Du; Xian Zhang; Luwei Han; Liwen Zhao; Ligong Lu; Hongzhi Du; Shengtao Yuan; Meixiao Zhan
Journal:  Acta Pharm Sin B       Date:  2021-03-09       Impact factor: 11.413

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.